This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

23andme has goldmine of genetic data to auction, but few safeguards govern its sale

By Maria Dinzeo ( March 28, 2025, 01:44 GMT | Comment) -- 23andMe’s most valuable asset is a trove of genomic and biometric data from some 15 million people, which the company plans to sell off to the highest bidder. While the company has said buyers will have to honor its existing privacy policy, the bankruptcy code offers limited protections. State regulators say they're closely following the case.DNA testing company 23andme’s chapter 11 bankruptcy announcement prompted a wave of alerts from state attorneys general urging customers to delete their data. Those alerts also came with a warning to the company: we’re watching you....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections